A Europe-wide strategy to enhance transplantation of highly sensitized patients on basis of Acceptable HLA mismatches
EUROSTAM is a project financed by the EC (FP7-HEALTH Collaborative project). The project started on 1 december 2012 and will last for three years.
The project adresses the FP7 workprogramme topic: Innovative approaches to solid organ transplantation.
Main aim of the project is to determine the feasibility and advantage to implement a Europe-wide acceptable mismatch program to facilitate transplantation of highly sensitized patients, who do not have a chance to be transplanted in their own population. The simulation studies on basis of the HLA phenotypes in different European populations will show the theoretical advantage of a Europe-wide acceptable mismatch program. The results of these studies will be published on the EUROSTAM website and in an international peer reviewed journal.
The major objective of the 10 partners in this project is to analyze the feasibility and requirements for a Europe-wide acceptable mismatch program to enhance transplantation of patients with rare HLA phenotypes in their own population. Read more ….
On December 8-9 2014, the Biannual Consortium Meeting was organised in Prague, Czech Republic.read more
On May 13-14 2014, the Midterm Meeting for EUROSTAM was organised in Athens. The local organiser was Aliki Iniotaki.read more
On September 19-20 2013, the second consortium meeting of EUROSTAM was organized by Institut D'Investigacions Biomediques August Pi I Sunyer (IDIBAPS) in Barcelona, Spain. The two day programme consisted of two meetings discussing the results and the future plans of...read more
The project has received funding from the European Union’s Seventh Framework Programme [FP7/2007-2013] under grant agreement number HEALTH-F4-2012-305385